Market Cap

Formycon AG Market Capitalization:

€847.6 Million

EUR as of Jan. 1, 2024

US$936.2 Million

business Formycon AG Company Profile

Formycon AG Main Stock Listings

Market Capitalization History of Formycon AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Formycon AG market cap

Date Market Cap YoY Change
Jan. 1, 2024 €847.6 M -37.62%
Jan. 1, 2023 €1.36 B 83.47%
Jan. 1, 2022 €740.6 M -14.48%
Jan. 1, 2021 €866.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Formycon AG Categories

Germany languages Healthcare languages Biotechnology
Germany Healthcare Germany Biotechnology

Stocks & Indices

Formycon AG has the following listings and related stock indices.


Stock: FSX: FYB

Stock: XETR: FYB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.